Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.
Medscape Medical News

source https://www.medscape.com/viewarticle/time-rethink-maintenance-pemetrexed-nsclc-2026a1000lqb?src=rss